サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1443393

白斑治療の世界市場規模調査＆予測：タイプ別、流通チャネル別、薬剤クラス別、地域別分析 2023-2030年

Global Vitiligo Treatment Market Size study & Forecast, by Type, by Distribution Channel, by Drug Class Type and Regional Analysis, 2023-2030
出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
白斑治療の世界市場規模調査＆予測：タイプ別、流通チャネル別、薬剤クラス別、地域別分析 2023-2030年
出版日: 2024年02月29日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の白斑治療市場は、2022年に約4億4,656万米ドルと評価され、予測期間2023-2030年には4.3％以上の健全な成長率で成長すると予測されています。

白斑は、色素を産生する細胞（メラノサイト）の喪失を特徴とする皮膚疾患で、皮膚に白い斑点が生じる。現在、尋常性白斑を治療する方法はないが、様々な治療法がこの状態を管理・コントロールすることを目的としています。治療法の選択は、色素脱失の程度、患者の年齢、全身の健康状態などの要因によって異なります。市場成長を促進する主な要因は、尋常性白斑の有病率の増加、美容治療に対する患者の需要の増加、尋常性白斑とその利用可能な治療法に関する認知度の増加であり、これらは予測期間2023-2030年の間に市場に有利な需要を創出すると予想されます。

さらに、世界の尋常性白斑の罹患率の上昇が、効果的な治療法の需要に寄与しています。遺伝的素因、自己免疫疾患、環境要因などが白斑の有病率上昇に寄与しています。Journal of the American Academy of Dermatologyによると、白い斑点を引き起こす皮膚疾患である白斑の世界の有病率は0.5％～2％です。欧州、日本、米国で行われた調査では、18歳以上の35,694人が参加し、全体の白斑有病率は1.3％でした。欧州が最も高く（1.6％）、米国（1.4％）、日本（0.5％）と続いた。白斑の徴候を認識している回答者352人のうち、62.2％が正式な診断を受けており、どの地域でも皮膚科医による診断が優勢でした。診断された患者の多くは45歳未満、女性、白人でした。89.5％が治療歴があると報告しました。この先駆的な研究は、多様な集団における白斑の有病率と人口統計学に関する貴重な洞察を提供するものです。その結果、白斑の有病率の高さが市場の成長をサポートすると予想されます。さらに、支持的なヘルスケア政策と償還、医療費の増加は、市場に有利な機会を創出すると予想されます。しかし、決定的な治療法の欠如と高額な治療費が、2023-2030年の予測期間を通じて市場の成長を阻害します。

白斑治療の世界市場調査において考慮した主要地域は、アジア太平洋、北米、欧州、ラテンアメリカ、中東・アフリカです。北米は、白斑症例の増加、治療技術の進歩、白斑に対する意識の高まりにより、2022年の市場を独占しました。一方、アジア太平洋地域は、白斑の有病率の増加、ヘルスケア支出の増加、一般人口とヘルスケア専門家の両方における白斑を含む皮膚疾患に対する意識の高まりなどの要因により、予測期間中に最も速い成長率で成長すると予想されます。

本調査の目的は、近年における様々なセグメントおよび国の市場規模を明らかにし、今後数年間の市場規模を予測することです。本レポートは、調査対象国における産業の質的・量的側面の両方を盛り込むよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場における潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

第2章 世界の白斑治療市場の定義と範囲

  • 調査目的
  • 市場の定義と範囲
    • 産業の進化
    • 調査範囲
  • 調査対象年
  • 通貨換算レート

第3章 白斑治療の世界市場力学

  • 白斑治療薬市場の影響分析（2020年～2030年）
    • 市場促進要因
      • 白斑の有病率の増加
      • 美容治療に対する患者の需要の高まり
      • 白斑とその治療法に関する認知度の向上
    • 市場の課題
      • 決定的な治療法の欠如
      • 高い治療費
    • 市場機会
      • 支持的なヘルスケア政策と診療報酬
      • 医療費の増加

第4章 白斑治療の世界市場産業分析

  • ポーターのファイブフォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターのファイブフォース影響分析
  • PEST分析
    • 政治
    • 経済
    • 社会
    • 技術
    • 環境
    • 法律
  • 主な投資機会
  • 主要成功戦略
  • COVID-19影響分析
  • 破壊的動向
  • 業界専門家の視点
  • アナリストの結論・提言

第5章 白斑治療の世界市場：タイプ別

  • 市場スナップショット
  • 白斑治療の世界市場：タイプ別実績-ポテンシャル分析
  • 白斑治療の世界市場：タイプ別推定・予測、2020-2030年
  • 白斑治療の市場：サブセグメント別分析
    • セグメント別
    • 非セグメント

第6章 白斑治療の世界市場：流通チャネル別

  • 市場スナップショット
  • 白斑治療の世界市場：流通チャネル別、実績 - ポテンシャル分析
  • 白斑治療の世界市場：流通チャネル別推定・予測、2020-2030年
  • 白斑治療の市場：サブセグメント分析
    • ドラッグストアと小売薬局
    • オンラインプロバイダー
    • 病院薬局

第7章 白斑治療の世界市場：薬剤クラス別

  • 市場スナップショット
  • 白斑治療の世界市場：薬剤クラス別、実績 - ポテンシャル分析
  • 白斑治療の世界市場：薬剤クラス別推定・予測、2020-2030年
  • 白斑治療薬市場：サブセグメント分析
    • 副腎皮質ステロイド
    • カルシニューリン阻害薬
    • その他

第8章 白斑治療の世界市場：地域別分析

  • 主要国
  • 主な新興国
  • 白斑治療薬市場、地域別市場スナップショット
  • 北米
    • 米国
    • カナダ
  • 欧州の白斑治療市場スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋の白斑治療市場スナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカの白斑治療市場スナップショット
    • ブラジル
    • メキシコ
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • その他中東とアフリカ

第9章 競合情報

  • 主要企業のSWOT分析
  • 主要市場戦略
  • 企業プロファイル
    • Clinuvel Pharmaceuticals Ltd.
    • Bausch Health Companies Inc.
    • Belcher Pharmaceuticals, LCC
    • Dr. Reddy's Laboratories Ltd.
    • Glenmark Pharmaceuticals Ltd.
    • Astellas Pharma Inc.
    • Pfizer Inc.
    • Strides Pharma Science Limited
    • Arcutis Biotherapeutics, Inc
    • Panacea Biotec Ltd.

第10章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • 検証
    • 出版
  • 調査属性
  • 調査前提条件
図表

LIST OF TABLES

  • TABLE 1. Global Vitiligo Treatment Market, report scope
  • TABLE 2. Global Vitiligo Treatment Market estimates & forecasts by region 2020-2030 (USD Million)
  • TABLE 3. Global Vitiligo Treatment Market estimates & forecasts by Type 2020-2030 (USD Million)
  • TABLE 4. Global Vitiligo Treatment Market estimates & forecasts by Distribution Channel 2020-2030 (USD Million)
  • TABLE 5. Global Vitiligo Treatment Market estimates & forecasts by Drug Class Type 2020-2030 (USD Million)
  • TABLE 6. Global Vitiligo Treatment Market by segment, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 7. Global Vitiligo Treatment Market by region, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 8. Global Vitiligo Treatment Market by segment, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 9. Global Vitiligo Treatment Market by region, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 10. Global Vitiligo Treatment Market by segment, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 11. Global Vitiligo Treatment Market by region, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 12. Global Vitiligo Treatment Market by segment, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 13. Global Vitiligo Treatment Market by region, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 14. Global Vitiligo Treatment Market by segment, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 15. Global Vitiligo Treatment Market by region, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 16. U.S. Vitiligo Treatment Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 17. U.S. Vitiligo Treatment Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 18. U.S. Vitiligo Treatment Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 19. Canada Vitiligo Treatment Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 20. Canada Vitiligo Treatment Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 21. Canada Vitiligo Treatment Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 22. UK Vitiligo Treatment Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 23. UK Vitiligo Treatment Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 24. UK Vitiligo Treatment Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 25. Germany Vitiligo Treatment Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 26. Germany Vitiligo Treatment Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 27. Germany Vitiligo Treatment Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 28. France Vitiligo Treatment Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 29. France Vitiligo Treatment Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 30. France Vitiligo Treatment Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 31. Italy Vitiligo Treatment Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 32. Italy Vitiligo Treatment Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 33. Italy Vitiligo Treatment Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 34. Spain Vitiligo Treatment Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 35. Spain Vitiligo Treatment Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 36. Spain Vitiligo Treatment Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 37. RoE Vitiligo Treatment Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 38. RoE Vitiligo Treatment Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 39. RoE Vitiligo Treatment Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 40. China Vitiligo Treatment Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 41. China Vitiligo Treatment Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 42. China Vitiligo Treatment Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 43. India Vitiligo Treatment Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 44. India Vitiligo Treatment Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 45. India Vitiligo Treatment Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 46. Japan Vitiligo Treatment Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 47. Japan Vitiligo Treatment Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 48. Japan Vitiligo Treatment Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 49. South Korea Vitiligo Treatment Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 50. South Korea Vitiligo Treatment Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 51. South Korea Vitiligo Treatment Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 52. Australia Vitiligo Treatment Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 53. Australia Vitiligo Treatment Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 54. Australia Vitiligo Treatment Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 55. RoAPAC Vitiligo Treatment Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 56. RoAPAC Vitiligo Treatment Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 57. RoAPAC Vitiligo Treatment Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 58. Brazil Vitiligo Treatment Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 59. Brazil Vitiligo Treatment Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 60. Brazil Vitiligo Treatment Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 61. Mexico Vitiligo Treatment Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 62. Mexico Vitiligo Treatment Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 63. Mexico Vitiligo Treatment Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 64. RoLA Vitiligo Treatment Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 65. RoLA Vitiligo Treatment Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 66. RoLA Vitiligo Treatment Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 67. Saudi Arabia Vitiligo Treatment Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 68. South Africa Vitiligo Treatment Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 69. RoMEA Vitiligo Treatment Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 70. List of secondary sources, used in the study of global Vitiligo Treatment Market
  • TABLE 71. List of primary sources, used in the study of global Vitiligo Treatment Market
  • TABLE 72. Years considered for the study
  • TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

  • FIG 1. Global Vitiligo Treatment Market, research methodology
  • FIG 2. Global Vitiligo Treatment Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Vitiligo Treatment Market, key trends 2022
  • FIG 5. Global Vitiligo Treatment Market, growth prospects 2023-2030
  • FIG 6. Global Vitiligo Treatment Market, porters 5 force model
  • FIG 7. Global Vitiligo Treatment Market, pest analysis
  • FIG 8. Global Vitiligo Treatment Market, value chain analysis
  • FIG 9. Global Vitiligo Treatment Market by segment, 2020 & 2030 (USD Million)
  • FIG 10. Global Vitiligo Treatment Market by segment, 2020 & 2030 (USD Million)
  • FIG 11. Global Vitiligo Treatment Market by segment, 2020 & 2030 (USD Million)
  • FIG 12. Global Vitiligo Treatment Market by segment, 2020 & 2030 (USD Million)
  • FIG 13. Global Vitiligo Treatment Market by segment, 2020 & 2030 (USD Million)
  • FIG 14. Global Vitiligo Treatment Market, regional snapshot 2020 & 2030
  • FIG 15. North America Vitiligo Treatment Market 2020 & 2030 (USD Million)
  • FIG 16. Europe Vitiligo Treatment Market 2020 & 2030 (USD Million)
  • FIG 17. Asia pacific Vitiligo Treatment Market 2020 & 2030 (USD Million)
  • FIG 18. Latin America Vitiligo Treatment Market 2020 & 2030 (USD Million)
  • FIG 19. Middle East & Africa Vitiligo Treatment Market 2020 & 2030 (USD Million)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

目次

Global Vitiligo Treatment Market is valued at approximately USD 446.56 million in 2022 and is anticipated to grow with a healthy growth rate of more than 4.3% during the forecast period 2023-2030. Vitiligo is a skin disorder characterized by the loss of pigment-producing cells (melanocytes), leading to the development of white patches on the skin. While there is currently no cure for vitiligo, various treatments aim to manage and control the condition. The choice of treatment depends on factors such as the extent of depigmentation, the patient's age, and overall health. The key factors driving the market growth are the increasing prevalence of vitiligo, rising patient demand for aesthetic treatments, and increasing awareness about vitiligo and its available treatments that anticipated to create a lucrative demand for the market during the forecast period 2023-2030.

Additionally, A rising incidence of vitiligo worldwide contributes to the demand for effective treatments. Factors such as genetic predisposition, autoimmune disorders, and environmental factors contribute to the increasing prevalence of vitiligo. According to the Journal of the American Academy of Dermatology, the global prevalence of vitiligo, a skin condition causing white patches, ranges from 0.5% to 2%. A survey across Europe, Japan, and the United States involved 35,694 participants aged 18 and above, revealing an overall vitiligo prevalence of 1.3%. Europe had the highest prevalence (1.6%), followed by the US (1.4%) and Japan (0.5%). Of 352 respondents aware of vitiligo signs, 62.2% received a formal diagnosis, with dermatologists predominantly diagnosing in all regions. Most diagnosed patients were under 45, female, and Caucasian. 89.5% reported previous treatments. This pioneering study provides valuable insights into vitiligo prevalence and demographics across diverse populations. As a result, the higher prevalence of vitiligo is anticipated to support the market growth. Moreover, supportive healthcare policies and reimbursement, and increasing healthcare expenditure are anticipated to create lucrative opportunities for the market. However, the lack of a definitive cure and high treatment costs stifle market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Vitiligo Treatment Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the rising incidence of vitiligo cases, advancements in treatment technologies, and increased awareness about vitiligo. Whereas, the Asia Pacific is expected to grow at the fastest growth rate over the forecast period, owing to factors such as the increasing prevalence of vitiligo, growing healthcare spending, and rising awareness about skin disorders, including vitiligo, among both the general population and healthcare professionals.

Major market player included in this report are:

  • Clinuvel Pharmaceuticals Ltd.
  • Bausch Health Companies Inc.
  • Belcher Pharmaceuticals, LCC
  • Dr. Reddy's Laboratories Ltd.
  • Glenmark Pharmaceuticals Ltd.
  • Astellas Pharma Inc.
  • Pfizer Inc.
  • Strides Pharma Science Limited
  • Arcutis Biotherapeutics, Inc
  • Panacea Biotec Ltd.

Recent Developments in the Market:

  • In Mar 2022, STRATA Skin Sciences, a pioneering medical technology company focused on advancing innovative solutions for autoimmune skin conditions, recently revealed its collaboration with the Global Vitiligo Foundation (GVF) as a corporate sponsor. The partnership underscores STRATA's commitment to developing, bringing to market, and promoting cutting-edge products for the effective treatment of diverse autoimmune skin diseases.

Global Vitiligo Treatment Market Report Scope:

  • Historical Data - 2020 - 2021
  • Base Year for Estimation - 2022
  • Forecast period - 2023-2030
  • Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered - Type, Distribution Channel, Drug Class Type, Region
  • Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

  • Segmental
  • Non-Segmental

By Distribution Channel:

  • Drug Stores and Retail Pharmacies
  • Online Providers
  • Hospital Pharmacies

By Drug Class Type:

  • Corticosteroids
  • Calcineurin Inhibitor
  • Others

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Million)
    • 1.2.1. Vitiligo Treatment Market, by Region, 2020-2030 (USD Million)
    • 1.2.2. Vitiligo Treatment Market, by Type, 2020-2030 (USD Million)
    • 1.2.3. Vitiligo Treatment Market, by Distribution Channel, 2020-2030 (USD Million)
    • 1.2.4. Vitiligo Treatment Market, by Drug Class Type, 2020-2030 (USD Million)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Vitiligo Treatment Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Vitiligo Treatment Market Dynamics

  • 3.1. Vitiligo Treatment Market Impact Analysis (2020-2030)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing prevalence of vitiligo
      • 3.1.1.2. Rising patient demand for aesthetic treatments
      • 3.1.1.3. Increasing awareness about vitiligo and its available treatments
    • 3.1.2. Market Challenges
      • 3.1.2.1. Lack of a definitive cure
      • 3.1.2.2. High treatment costs
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Supportive healthcare policies and reimbursement
      • 3.1.3.2. Increasing healthcare expenditure

Chapter 4. Global Vitiligo Treatment Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Impact Analysis
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. COVID-19 Impact Analysis
  • 4.7. Disruptive Trends
  • 4.8. Industry Expert Perspective
  • 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Vitiligo Treatment Market, by Type

  • 5.1. Market Snapshot
  • 5.2. Global Vitiligo Treatment Market by Type, Performance - Potential Analysis
  • 5.3. Global Vitiligo Treatment Market Estimates & Forecasts by Type 2020-2030 (USD Million)
  • 5.4. Vitiligo Treatment Market, Sub Segment Analysis
    • 5.4.1. Segmental
    • 5.4.2. Non-Segmental

Chapter 6. Global Vitiligo Treatment Market, by Distribution Channel

  • 6.1. Market Snapshot
  • 6.2. Global Vitiligo Treatment Market by Distribution Channel, Performance - Potential Analysis
  • 6.3. Global Vitiligo Treatment Market Estimates & Forecasts by Distribution Channel 2020-2030 (USD Million)
  • 6.4. Vitiligo Treatment Market, Sub Segment Analysis
    • 6.4.1. Drug Stores and Retail Pharmacies
    • 6.4.2. Online Providers
    • 6.4.3. Hospital Pharmacies

Chapter 7. Global Vitiligo Treatment Market, by Drug Class Type

  • 7.1. Market Snapshot
  • 7.2. Global Vitiligo Treatment Market by Drug Class Type, Performance - Potential Analysis
  • 7.3. Global Vitiligo Treatment Market Estimates & Forecasts by Drug Class Type 2020-2030 (USD Million)
  • 7.4. Vitiligo Treatment Market, Sub Segment Analysis
    • 7.4.1. Corticosteroids
    • 7.4.2. Calcineurin Inhibitor
    • 7.4.3. Others

Chapter 8. Global Vitiligo Treatment Market, Regional Analysis

  • 8.1. Top Leading Countries
  • 8.2. Top Emerging Countries
  • 8.3. Vitiligo Treatment Market, Regional Market Snapshot
  • 8.4. North America Vitiligo Treatment Market
    • 8.4.1. U.S. Vitiligo Treatment Market
      • 8.4.1.1. Type breakdown estimates & forecasts, 2020-2030
      • 8.4.1.2. Distribution Channel breakdown estimates & forecasts, 2020-2030
      • 8.4.1.3. Drug Class Type breakdown estimates & forecasts, 2020-2030
    • 8.4.2. Canada Vitiligo Treatment Market
  • 8.5. Europe Vitiligo Treatment Market Snapshot
    • 8.5.1. U.K. Vitiligo Treatment Market
    • 8.5.2. Germany Vitiligo Treatment Market
    • 8.5.3. France Vitiligo Treatment Market
    • 8.5.4. Spain Vitiligo Treatment Market
    • 8.5.5. Italy Vitiligo Treatment Market
    • 8.5.6. Rest of Europe Vitiligo Treatment Market
  • 8.6. Asia-Pacific Vitiligo Treatment Market Snapshot
    • 8.6.1. China Vitiligo Treatment Market
    • 8.6.2. India Vitiligo Treatment Market
    • 8.6.3. Japan Vitiligo Treatment Market
    • 8.6.4. Australia Vitiligo Treatment Market
    • 8.6.5. South Korea Vitiligo Treatment Market
    • 8.6.6. Rest of Asia Pacific Vitiligo Treatment Market
  • 8.7. Latin America Vitiligo Treatment Market Snapshot
    • 8.7.1. Brazil Vitiligo Treatment Market
    • 8.7.2. Mexico Vitiligo Treatment Market
  • 8.8. Middle East & Africa Vitiligo Treatment Market
    • 8.8.1. Saudi Arabia Vitiligo Treatment Market
    • 8.8.2. South Africa Vitiligo Treatment Market
    • 8.8.3. Rest of Middle East & Africa Vitiligo Treatment Market

Chapter 9. Competitive Intelligence

  • 9.1. Key Company SWOT Analysis
    • 9.1.1. Company 1
    • 9.1.2. Company 2
    • 9.1.3. Company 3
  • 9.2. Top Market Strategies
  • 9.3. Company Profiles
    • 9.3.1. Clinuvel Pharmaceuticals Ltd.
      • 9.3.1.1. Key Information
      • 9.3.1.2. Overview
      • 9.3.1.3. Financial (Subject to Data Availability)
      • 9.3.1.4. Product Summary
      • 9.3.1.5. Recent Developments
    • 9.3.2. Bausch Health Companies Inc.
    • 9.3.3. Belcher Pharmaceuticals, LCC
    • 9.3.4. Dr. Reddy's Laboratories Ltd.
    • 9.3.5. Glenmark Pharmaceuticals Ltd.
    • 9.3.6. Astellas Pharma Inc.
    • 9.3.7. Pfizer Inc.
    • 9.3.8. Strides Pharma Science Limited
    • 9.3.9. Arcutis Biotherapeutics, Inc
    • 9.3.10. Panacea Biotec Ltd.

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption